NYSE | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | Healthcare | Biotechnology | 5.52% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 5.20% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 4.70% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| BRKR | Bruker Corporation | Healthcare | Medical Devices | 4.50% |
| NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | 4.25% |
| ONC | BeiGene, Ltd. | Healthcare | Biotechnology | 4.23% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.03% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.00% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.91% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.85% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.84% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.81% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.58% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.57% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.49% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 3.41% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |